27 June 2014 | News | By BioSpectrum Bureau
Singapore: The 2014 BIO International Convention, the world's largest and most prestigious biotechnology event, attracted pioneers and industry leaders from 65 countries worldwide. The three day event that started on June 23 was held at the San Diego Convention Center.
The event witnessed participation of many global leaders who shared ideas, experiences, insights and best practices on biotech innovations that would help solve some of the biggest global challenges, like emerging diseases, improving health, feeding growing populations and meeting the increased world demand for energy.
Hosted by the Biotechnology Industry Organisation, the event featured around 3,000 biotechnology companies and 15,000 attendees.
"San Diego is one of the third largest life sciences clusters in the country. By hosting the 2014 BIO International Convention, we will have the opportunity to showcase all that San Diego has to offer as a global leader in the life sciences," said San Diego interim Mr Mayor Todd Gloria.
The convention program featured more than 160 sessions and nine specialty forums. Each forum hovered over trending biotech concerns like emerging diseases, orphan diseases, personalized medicine, digital health, intellectual property rights etc.
Global experts offered insights on issues essential to the industry and provided a wealth of information of strategic relevance to improvise biotech businesses. Latest trends and newer opportunities were highlighted and breakthroughs in medicine, diagnostics, environment, business operations, financing, partnerships, policy issues, food and agriculture were discussed.
The BIO Exhibition event saw the display of cutting edge technologies by various life science pioneers and startups. It featured more than 1,700 exhibitors, from 60 sates providing high opportunity to discover new players in the industry, form partnerships and evaluate emerging technologies.
The digital health technology that is currently creating waves in the market was also exhibited at the convention that helped pharmaceutical and biotech companies to seek partners and develop patient centric solutions.
Bio-one-on-one partnering at the convention provided the most efficient and economical way to establish global partnerships, driving major successful deals in the pharmaceutical industry.
The convention also featured the BIO Business Forum, which gave an opportunity to global giants for clinching with the most beneficial deals. The convention saw record breaking participation with over 28,000 meetings held across various domains.